|Publication number||US20040249363 A1|
|Application number||US 10/869,978|
|Publication date||Dec 9, 2004|
|Filing date||Jun 17, 2004|
|Priority date||Jan 11, 2000|
|Also published as||CA2392164A1, CA2392164C, DE60124671D1, DE60124671T2, EP1253957A1, EP1253957B1, US6764472, US7108686, US20030208184, WO2001051108A1|
|Publication number||10869978, 869978, US 2004/0249363 A1, US 2004/249363 A1, US 20040249363 A1, US 20040249363A1, US 2004249363 A1, US 2004249363A1, US-A1-20040249363, US-A1-2004249363, US2004/0249363A1, US2004/249363A1, US20040249363 A1, US20040249363A1, US2004249363 A1, US2004249363A1|
|Inventors||Paul Burke, Kenneth Fine|
|Original Assignee||Bard Access Systems, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (99), Referenced by (10), Classifications (11), Legal Events (1)|
|External Links: USPTO, USPTO Assignment, Espacenet|
 This application is a continuation of U.S. application Ser. No. 09/481,298, filed Jan. 11, 2000, now pending.
 The invention relates to implantable infusion devices for controllable in vivo delivery of drugs to a patient.
 Implantable infusion devices provide a patient with an in vivo source of a drug to be administered, in a device which permits controlled delivery of the drug over a predetermined time period. Certain drugs, such as, for example, chemotherapy drugs and opioids, may be most effective if administered at a constant dose rate, instead of at discrete intervals.
 A typical infusion device or pump includes a hermetically sealed outer housing which holds a vapor pressure fluid or other means for exerting a compressive force on a compressible or flexible inner drug reservoir which communicates with a drug delivery port. Alternatively, the drug may be disposed in the outer housing, with a propellant disposed in the inner housing. When the outer housing is filled with the drug, the propellant in the inner housing is compressed and changes state from a vapor to a liquid, thereby recharging the driving mechanism of the device. In still other embodiments, the outer housing may be divided into two chambers separated by a liquid-impermeable diaphragm. One chamber contains the drug and includes a drug delivery port, and the other chamber contains a propellant or spring member for exerting a force against the diaphragm so as to expel the drug through the delivery port.
 The infusion device must meet numerous requirements for safety and efficacy. For example, the housing material must not react with body fluids or with the drugs and propellants inside the housing. Further, the membrane or flexible barrier between the chambers must not leak and must be impermeable to gas-phase fluids so as to prevent contamination of the drug with the propellant. Since the device is designed for implantation into a patient, great care must be taken to prevent any leakage of either the drug or the propellant into the patient's body. In addition, the device is desirably as small and lightweight as possible so as to cause minimum invasive trauma, discomfort and disfigurement to the patient, yet sufficiently large to provide a useful therapeutic dosage of the drug being administered and minimize the frequency with which the device must be recharged. It is desirable to make the pump refillable so that it need not be surgically removed and replaced when the drug is depleted. However, refillability of the pump requires a port which is either outside of the skin or transcutaneously accessible without introducing infection or risking the release of an excessive and potentially harmful amount of the drug into the patient. Also, in those devices in which a propellant is contained within a flexible bag which expands and contracts in response to changes in the propellant pressure, it is necessary to ensure that introduction of the drug to the drug reservoir surrounding the propellant bag is not impeded by the presence and location of the bag in the reservoir and/or does not puncture or pinch the bag. Thus, it may be necessary to affix the propellant chamber or bag to the housing so as to avoid such problems. There is the additional problem of ensuring that the drug reservoir can be fully depleted and refilled, for optimum efficiency of the device.
 Administration of a desired dosage of a drug over a period of time may require a controllable, constant flow of the drug from the device. However, as the drug is depleted from the reservoir, or if the force exerted on the drug reservoir cannot be controlled, a constant dose rate may be difficult to sustain.
 U.S. Pat. No. 3,840,009 to Michaels et al. discloses a vapor pressure drug delivery device which has two chambers separated by a flexible wall or bladder. The outer chamber contains a drug to be administered to a patient, and the inner chamber contains a pressure fluid which expands to conform to the shape of the outer chamber, thereby enabling expulsion of substantially all of the drug within the outer chamber. The pressure fluid is maintained at a positive pressure at the temperature at which the device is used, so that no external power source is required.
 U.S. Pat. No. 5,167,633 to Mann et al. discloses a medication infusion pump in which a constant pressure is exerted on a liquid medication to be administered. The pump includes a pressure reservoir in the form of a hollow enclosure with at least one flexible wall for containing a pressure fluid. The medication to be administered is outside of the pressure reservoir. The pressure fluid undergoes a phase change from a liquid to a vapor so as to expel the drug from the pump. The Mann et al. device is maintained at a negative pressure at the temperature of use to avoid leakage of medication from the pump into the patient.
 U.S. Pat. No. 5,514,103 to Srisathapat et al. discloses a medication infusion pump including a drug reservoir and a pressure fluid reservoir which are separated by a movable wall or flexible bag. The pressure fluid reservoir includes a spacer therein to prevent contraction of the pressure fluid reservoir below a minimum volume which is slightly greater than the liquid phase volume of the pressure fluid, so that a portion of the pressure fluid always remains in a vapor phase. As a result, even when the drug reservoir is completely filled, the pressure fluid is not entirely in the liquid phase. Thus, additional energy to reinstate a vapor phase is not required.
 U.S. Pat. No. 3,951,147 to Tucker et al. discloses a refillable implantable infusate pump in which a bellows containing a drug is contained within a housing which is filled with a pressure fluid or propellant. The Tucker et al. pump includes a filtering chamber to ensure removal of debris from the infusate drug prior to its delivery to the patient.
 U.S. Pat. No. 5,045,064 to Idriss discloses a constant pressure implantable pump which employs shape-memory metal bands around a reservoir containing a fluid to be infused. The bands compress the reservoir containing the fluid to be infused, thereby eliminating the need for a propellant.
 U.S. Pat. No. 5,395,324 to Hinrichs et al. discloses an infusion pump having a primary entry port leading to a drug reservoir, a separate bolus port leading to a bolus chamber, and means for ensuring that the bolus chamber is not inadvertently filled with the drug intended for the primary drug reservoir.
 U.S. Pat. No. 5,769,823 to Otto discloses an implantable infusion pump which comprises a plastic housing, a bellows chamber enclosing a propellant, and two separate resilient plastic bags enclosing an infusate. The bags are surrounded by glycerin or the like which binds with any propellant passing through the bellows wall into the housing, thereby preventing passage of the propellant through the housing into the patient.
 U.S. Pat. No. 5,575,770 to Melsky et al. discloses an implantable infusion pump having a valve-actuated bolus delivery chamber. Inadvertent administration of an overdose to the patient through the bolus delivery chamber is prevented by a design which requires the use of a side-access delivery needle, which is inserted through a pair of septa which are spaced apart to define a bolus chamber. The tip of the needle extends beyond the lower septum and depresses a lever to actuate the normally-closed valve. The side opening of the needle is disposed between the septa in the bolus chamber for delivery of the bolus dose to the bolus chamber. The design prevents erroneous dose delivery by requiring the simultaneous opening of the valve with delivery of the drug into the bolus using a side-access delivery needle.
 It would be advantageous to provide an implantable infusion pump which is of simple construction and operation, made of lightweight materials, inexpensive to manufacture, efficient in the delivery of medicine, and easy to refill.
 According to one aspect of the invention, there is provided an implantable infusion device, comprising a housing having an annular portion with an inner wall defining an interior region having a width dimension ID and extending along a central axis, a bottom portion extending from the annular portion and spanning a first end of the interior region, and a top portion extending from the annular portion and spanning a second end of the interior region and being opposite the bottom portion, the interior region being substantially closed. The device further includes a closed fluid-impermeable hollow bellows extending from one of the top and bottom portions of the housing and defining a variable volume region therein and having a plurality of serially coupled annular members extending between top and bottom portions of the bellows. Junctions of the coupled annular members are coupled with flexures. The bellows has a maximum outer width dimension D′ where D′ is less than D. The portion of the housing from which the bellows extends includes a substantially planar annular peripheral portion disposed about a central portion. A pressure source is contained within the variable volume region of the bellows. The bellows is disposed within the interior region of the housing and rigidly coupled to the portion of the housing from which it extends. The annular members, of the bellows are spaced apart from the annular portion of the housing. The housing includes a recharging fluid flow path from points external to the housing to a region adjacent to the central portion of the portion of the housing from which the bellows extends. The housing further defines a fluid exit flow path extending from the region between the bellows and the annular portion of the housing to points external to the housing.
 The device further includes a pierceable, self-sealing septum disposed in the recharging fluid flow path and may further include a recharging fluid reservoir disposed along the recharging fluid flow path. The septum may be removable from the housing.
 The device further includes at least one of a flow restrictor and a filter disposed along the fluid exit flow path.
 In one embodiment, the housing is made of a gas-impermeable material, and the bellows which encloses the pressure source is made of a substantially rigid, gas-impermeable material. In a preferred embodiment, the bellows is hermetically sealed.
 The pressure source comprises one or more of the group consisting of multiple-phase fluids, springs, shape memory metal alloys, Belville washers, and compressible materials. In one embodiment, a multiple-phase fluid propellant is present in at least one of a liquid phase and a gas phase within the variable volume region of the bellows as a function of ambient temperature. Conversion of the propellant fluid from a liquid phase to a gas phase increases the volume displaced by the bellows in the interior region of the housing, thereby exerting a force on a fluid external to the bellows in the housing so as to provide a substantially constant flow rate of the fluid through the fluid exit flow path.
 In a preferred embodiment, the propellant is disposed in the variable volume region of the bellows at a pressure which is not less than atmospheric pressure at ambient temperature.
 In one embodiment, the central portion of the bellows is offset from the plane of the annular peripheral portion of said bellows. A central region of the portion of the housing from which the bellows extends is correspondingly offset from the plane of the annular portion of the housing. The offset central region of the housing substantially nests within the offset central portion of the bellows.
 In one embodiment, the housing and bellows are cylindrical.
 The device can further include a separate bolus port in fluid communication with the fluid exit flow path. The bolus port can include a pair of septa which are spaced apart to define a bolus reservoir therebetween. A side-access delivery needle having an opening near the center of its length is required to delivery a bolus dose of the infusate to the bolus reservoir.
 In one preferred embodiment, the bellows extends from the top portion of the housing. In another preferred embodiment, the bellows extends from the bottom portion of the housing.
 According to another aspect of the invention, there is provided an implantable infusion device, comprising a housing having an annular portion with an inner wall defining an interior region having a width dimension D and extending along a central axis, a bottom portion extending from the annular portion and spanning a first end of the interior region, and a top portion extending from the annular portion and spanning a second end of the interior region, the top portion being opposite the bottom portion, the interior region being substantially closed. The device further includes a closed fluid-impermeable hollow bellows disposed about a variable volume region and having a top member, a bottom member, and a plurality of serially coupled annular members extending therebetween. Junctions of the coupled annular members are coupled with flexures. The bellows has a maximum outer width dimension D′ where D′ is less than D. At least one of the top and bottom members includes a substantially planar annular peripheral portion disposed about a central portion. A pressure source is contained within the variable volume region of the bellows, and the bellows is disposed within the interior region of the housing with one of the top and bottom members facing and rigidly coupled to a corresponding portion of the housing. The annular members of the bellows are spaced apart from the annular portion of the housing. The housing includes a recharging fluid flow path from points external to the housing to a region adjacent to the central portion of one of the top and bottom members of the bellows. The region of coupling between the housing and the bellows defines a fluid dispersal flow path from the region adjacent to the central portion of the coupled member of the bellows to a region between the annular members of the bellows and the annular portion of the housing. The housing further defines a fluid exit flow path extending from the region between the bellows and the annular portion of the housing to points external to the housing.
 In one embodiment, a central portion of at least one of the top and bottom members of the bellows is offset from the plane of the annular peripheral portion of the top and bottom members of the bellows. A central region of the portion of the housing which is coupled to the bellows is correspondingly offset from the plane of the annular portion of the housing, so that the offset central region of the portion of the housing which is coupled to the bellows nests within the central portion of the coupled portion of the bellows.
 In one preferred embodiment, the bellows is coupled to the top portion of the housing. In another preferred embodiment, the bellows is coupled to the bottom portion of the housing.
 According to still another aspect of the invention, there is provided a septum replacement kit for an enclosed device which is sealed with a septum, wherein the enclosed device defines a fluid reservoir, a fluid flow inlet and a fluid flow outlet. The kit comprises a compressible septum adapted to sealingly engage in the fluid flow inlet of the reservoir, and a septum installation tool adapted to compress the septum to a nominal insertion size, maintain the nominal insertion size of the septum prior to installation of the septum, and install the septum in the fluid flow inlet of the reservoir.
 The septum installation tool preferably comprises a tubular member adapted for insertion into the fluid flow inlet of the reservoir, an opening in the tubular member for insertion and retention of the septum therein, and a plunger member disposable in the tubular member for expulsion of the septum from the tubular member. Insertion of the septum into the tubular member compresses the septum. Expulsion of the septum from the tubular member into the fluid inlet reservoir permits the septum to expand to fill in and seal the fluid inlet reservoir.
 The septum is preferably made of a pierceable, self-sealing elastomeric or rubber-like material.
 These and other objects and advantages of the invention will in part be obvious and will in part appear hereinafter. The invention accordingly comprises the apparatus possessing the construction, combination of elements and arrangement of parts which are exemplified in the following detailed disclosure, the scope of which will be indicated in the claims.
 For a fuller understanding of the nature and objects of the present invention, reference should be made to the following detailed description taken in connection with the accompanying drawings, in which:
FIG. 1 is a perspective view of an infusion device according to the invention;
FIG. 2 is a schematic diagram of the device which illustrates its structure and principles of operation;
FIG. 3 is a sagittal view of the device of FIG. 1;
FIG. 4 is a sagittal view of an alternate design of the device, in which the sideport bolus port is located at an angle on a peripheral edge of the device;
FIG. 5 is a sagittal view of a replaceable septum in a device according to the present invention;
FIGS. 6A-6C illustrate a septum replacement kit and the steps for installing a replacement septum with a septum replacement tool; and
FIGS. 7A-7B illustrate a bolus port safety feature which prevents inadvertent administration of an overdose of drug to the patient through the bolus injection port.
 Like features in the drawings are indicated with like numerals.
 The infusion device of the present invention combines several features known in the art in a novel and unobvious way. The device has a relatively low profile, as shown in FIGS. 1, 3 and 4, and is remarkable in several aspects. First, the device can be housed in a lightweight, biologically inert material which need not be hermetically sealed. This is because, unlike most prior art infusion devices, the pressure source in the claimed device, which can be a propellant fluid, a mechanical spring or the like, or a combination of such elements, is contained in a separate enclosed container within the housing of the device, and the infusate, or drug to be administered, is outside the container containing the pressure source.
 The container for the pressure source ideally is in the form of a variable volume container, such as a metal bellows or a flexible bag or envelope. However, unlike an expandable balloon bag, the variable volume container has a defined maximum and minimum volume. The infusate is administered to the patient from the device upon expansion of the variable volume container within the interior region of the housing until the variable volume container effectively fills the interior volume of the housing, at which point the infusate is substantially depleted.
 The device can also be transcutaneously recharged with infusate without requiring that the device be removed from the patient. Recharging the infusate effectively recharges the pressure source by compressing the variable volume container to its minimum volume and creating pressure which is used to expel the infusate from the device.
 The device also includes a separate bolus injection port for introduction of a bolus dose to the patient which bypasses the pressure source-driven delivery of the infusate from the principal reservoir of the device. Pierceable, self-sealing septa through which infusate can be injected into the device are located in the primary and bolus ports of the device for convenient introduction and containment of infusate and bolus injections.
 In addition, because the housing can be made of a lightweight material, such as plastic, many features, such as fluid flow channels, compartments, needle stops and suture loops, can be integrated into the housing during its manufacture, which can be accomplished by molding or other low-cost, high-volume manufacturing processes.
FIG. 1 shows a perspective view of the infusion device 10 according to the invention. FIG. 2 illustrates in schematic form the basic structure and principle of operation of the device. FIG. 3 is a detailed sectional view of the device of FIG. 1 along a sagittal (vertical longitudinal) axis. FIG. 4 is a sagittal view of an alternate design of the device, in which the side bolus port is located at an angle from a top edge of the device. FIG. 5 is a sagittal view of a replaceable septum for the device. FIGS. 6A-6C illustrate a septum replacement kit and a method of using it to remove a worn septum and replace it with a fresh septum. FIGS. 7A-7B illustrate a bolus safety feature which prevents the inadvertent administration of a principal dose of the drug to be infused through the bolus injection port.
 The device 10 is contained within a housing 12 made of a lightweight, durable, and biologically inert material, such as plastic. The housing is conveniently formed of an upper housing 12 a and a lower housing 12 b, which are joined with an o-ring 14 between them to create a fluid-impermeable seal. The halves of the housing can be joined by, for example, ultrasonic or thermal welding, solvent bonding, or other adhesive-based bonding.
 The housing of the device defines an interior region which forms a principal reservoir 16 for the infusate 18, which is typically a drug to be administered over a period of time at a constant low dose to a patient into which the device has been surgically implanted. The infusate is introduced into the principal reservoir via a principal entry port 20, which is sealed with a pierceable, self-sealing septum 22. The infusate is delivered from the principal reservoir to a catheter 24 via exit flow path 25, which may contain at least one of a filter 26 and a flow restrictor 28.
 In one preferred embodiment of the invention, the device can include a separate restrictor chamber in the upper half 12 a. This separate restrictor chamber permits the use of interchangeable restrictors for establishing different infusate flow rates.
 Delivery of the infusate from the principal reservoir is driven by a pressure source P contained within a variable volume enclosed chamber 30, which may be attached to the housing, preferably to the upper housing 12 a, as detailed more fully below. The pressure source may be a multiple-phase fluid which expands from a liquid phase to a gas phase with increasing temperature, thereby increasing in volume and pushing against the walls of the variable volume container to enlarge it, thereby decreasing the volume of the principal reservoir 16 and expelling the infusate therein from the device. Alternatively, the pressure source can be a mechanical device, such as a spring or other compressible member, or a shape-memory metal alloy. A combination of a propellant fluid and a compressible mechanical member may also be used to obtain a desired infusate delivery rate from the device. The mechanical member may, but need not, exert a constant force throughout its stoke range.
 If a propellant fluid is used as the pressure source within the variable volume chamber, it is desirable to have the minimum volume of the chamber be greater than the liquid volume of the propellant fluid, so that the propellant fluid must always exist in the chamber in both liquid and gas phases. In addition, it is desirable to select a propellant fluid which is at a pressure of not less than one atmosphere at ambient temperature, so that at the temperature of use (typically nominal body temperature of the patient) the propellant is at a pressure which is even higher than one atmosphere of pressure. This allows the surgeon to prime and operate the device at ambient temperature in order to verify its performance prior to implantation of the device in the patient, thereby eliminating the need to warm the device and the infusate to body temperature. In addition, such a positive pressure device eliminates the risk that outside air or gases will be drawn into the device during storage of the device.
 The inert plastic housing containing the infusate 12 may, but need not, be hermetically sealed. The housing, if made of a moldable or easily formed material, may include, for example, integrally formed needle stops 32, 34 for the primary and bolus injection sites, as well as one or more integrally formed suture loops 36 for passage of anchoring sutures therethrough.
 The variable volume chamber 30 is desirably a substantially rigid, gas-impermeable bellows structure, as illustrated in FIGS. 3 and 4, or other similar rigid-walled or spring-driven structure which occupies a volume which approximates the volume of the principal reservoir 16. Preferred materials for the bellows chamber include metals and plastics. An important feature of the variable volume chamber is its width dimension or diameter D′ relative to the diameter D of the housing. It is necessary to have D′ be less than D, so that the bellows walls are spaced from the housing walls, but only by so much as will allow the bellows walls to move freely within the housing. It is desirable to have the bellows walls as close as possible to the housing walls so that maximum displacement of infusate can be achieved by movement of the bellows in the reservoir. However, drag of the bellows walls on the housing walls must be avoided. Thus, it is desirable to have the variable volume chamber centered in the principal reservoir for maximum volume and avoidance of drag and so that the distance D-D′ is sufficient to avoid such drag.
 Although the device and bellows are illustrated as cylindrical in a preferred embodiment, they may have any convenient shape.
 Another important consideration is that the variable volume chamber must not be located so that it obstructs the principal entry port for infusate when the principal reservoir is empty and the variable volume chamber is at its maximum volume. In a preferred embodiment, the variable volume chamber 30 may be attached to the housing so as to define a fluid flow path between the variable volume chamber and the housing. Alternatively, the chamber 30 and housing 12 may be designed to share a common wall which may be channeled to provide fluid flow paths along the interface between the housing and the chamber 30. In still another alternate embodiment, the bellows may be freely located in the interior region of the housing. In this embodiment, the free bellows is desirably held away from the infusate entry port by standoffs extending from the bellows or from the infusate entry port.
 To ensure as low a profile as possible for the device, it is desirable to construct the housing so that the central portion of one or both of its top and bottom portions, along with corresponding central portions of the top and bottom members of the bellows, is offset or depressed from the nominal plane of the central portions as shown in FIGS. 3 and 4 to form a nested structure. The infusate entry port nests within a recessed central portion of the bellows. Although only the top portions of the housing and bellows are shown as nested in FIGS. 3 and 4, the bottom portions of the housing and bellows could also be nested to further reduce the height of the device. Reductions in the volume of the infusate chamber 30 reduce the amount of infusate that can be administered and increase the frequency with which the chamber 30 must be recharged if drug delivery is to take place over an extended period. However, the pressure source can be selected so as to maximize delivery from a given volume.
 The device includes a separate bolus injection port 38, which includes a bolus entry port 40 sealed with a pierceable, self-sealing septum 42, and leading to a bolus reservoir 44, which is in fluid communication with the fluid exit flow path 25 and delivery catheter 24, yet downstream of the filter 26 and flow restrictor 28. Infusate introduced into the bolus port goes directly into the delivery catheter and bypasses the controlled release provided by the action of the pressure source and variable volume chamber on the infusate in the principal reservoir.
 Both the principal infusate entry port and the bolus injection port may include sensing devices known in the art which assist the patient and medical staff in locating the devices transdermally so that additional infusate can be introduced to the device without the need for external palpation or surgical removal of the device.
 The life of an implantable infusion device such as those described herein is determined in large part by the life of the septum through which the infusate is introduced. Use of a self-sealing material, such as an elastomer, silicone rubber or similar material, for the septum allows the septum to reseal after it has been pierced with a needle. However, even self-sealing materials lose some elasticity after a certain number of uses and must be replaced to ensure that no infusate leaks out of the device.
 Septum life, and thus infusion device life, can be optimized by careful selection of the septum material and the dimensions of the septum and the septum chamber in the device. This is shown in FIG. 5. The ratio of the opening dimension of the septum chamber (B) to the width of the septum chamber (A) must be such that the entire septum volume can fit within the chamber opening B when the septum is compressed, and such that the chamber width A adequately compresses the septum to provide satisfactory puncture life. The selection of a material for the septum is also an important consideration, as its hardness, as measured by a durometer, must allow for adequate compression of the septum during insertion without comprising puncture life. The height of the septum chamber (C) must be sufficient to permit the compressed septum to fill the chamber and still be sufficiently axially compressed to achieve the desired puncture life.
 A septum replacement kit allows the surgeon to replace a worn septum without surgically removing the device from the patient. Such a kit is illustrated in FIGS. 6A-6C. FIG. 6A shows a septum 22, which is typically in the form of a cylindrical or square plug of height H and width W. The septum is preferably made of a compressible, resilient, penetrable, self-sealing material, such as a rubber or elastomer. FIG. 6B shows the septum lodged in a tubular member 46, which is sized to fit into the entry port 20, having width B, of the infusion device 12. The septum is easily compressed sufficiently to be lodged into the tubular member 46, and a plunger 48 is used to dislodge the septum from the tubular member into the septum chamber 50, which has width A and height C, after it is inserted into the entry port 20, as shown in FIG. 6C. The septum is radially compressed in the chamber to form a penetrable seal. The plunger and tubular member can then be withdrawn.
 Removal of a worn septum can be accomplished by inserting a sharp instrument into the septum to cut it into sections that can then be removed from the septum chamber with tweezers or other suitable instrument.
 Although the FIGS. illustrate use of the septum replacement kit for replacing the primary septum 22, the kit can also be used to replace the bolus septum 42 in the bolus injection port 40.
 In addition, the device may include safety filling devices known in the art to ensure that the patient and medical staff can distinguish between the primary entry port and the bolus injection port so as to avoid inadvertent administration of relatively large doses intended to be administered over time to the patient. When an implanted infusion pump is to be refilled, it may be difficult to determine whether a refill needle is positioned to enter the principal infusate port or the bolus port. Entry of the refill needle into the wrong port for the dose being administered can result in a patient receiving an excessive dose of the drug and therefore must be prevented.
 A bolus safety feature in accordance with the present invention is shown and described in connection with FIGS. 7A-7B. FIG. 7A illustrates the two infusate ports in a typical implantable infusion pump according to the invention. The device includes a principal, or center, access port (1) for administration of infusate into the device, and a bolus access port (2) for administration of a bolus injection directly to the patient. The center access port (1) includes a single septum, below which is disposed an infusate reservoir R. To fill the center access port (1), a refill needle having a hole in the tip, as shown in (1), is required.
 In contrast, the side bolus access port (2) includes two septa which are spaced apart to define an infusate reservoir R between them. The top septum in the bolus access port (2) secures the delivery needle in place and provides a seal to prevent leakage of the bolus dose once the needle is removed from the bolus port. The bottom septum blocks the opening in the tip of a standard refill needle, shown in (1), should such a needle be inserted into the bolus port. Only a special needle with a side-access opening near the center of its length, as shown in (2), instead of at or near the tip, as shown in (1), can be used to fill the bolus port.
FIG. 7B shows the result of using a standard delivery needle in the bolus port. The standard delivery needle includes an opening at its tip and no opening in the side. The opening in the tip will be blocked by the lower septum when the needle is inserted into the bolus port, and no infusate will be delivered.
 This design of the center and bolus ports in the device of the invention ensures that no bolus dose can be administered inadvertently to a patient, because only a bolus (side-access opening) needle can be used in the bolus port. If a standard delivery needle is accidentally inserted into the bolus port, no infusate can be delivered, and the surgeon can see immediately that the wrong needle is being toed, without administering any harmful dose to the patient.
 Because certain changes may be made in the above apparatus without departing from the scope of the invention herein disclosed, it is intended that all matter contained in the above description or shown in the accompanying drawings shall be interpreted in an illustrative and not a limiting sense.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3682315 *||Oct 20, 1969||Aug 8, 1972||Haller Wolfgang||Cartridge type column for treatment of liquid streams and substrate enclosure therefor|
|US3731681 *||Jan 14, 1972||May 8, 1973||Univ Minnesota||Implantable indusion pump|
|US3896806 *||Dec 21, 1971||Jul 29, 1975||Ceskoslovenska Akademie Ved||Implant for directed infusion of biologically active substances|
|US3971376 *||Oct 2, 1974||Jul 27, 1976||Ceskoslovenska Akademie Ved||Method and apparatus for introducing fluids into the body|
|US4146029 *||May 31, 1977||Mar 27, 1979||Ellinwood Jr Everett H||Self-powered implanted programmable medication system and method|
|US4193397 *||Feb 5, 1979||Mar 18, 1980||Metal Bellows Corporation||Infusion apparatus and method|
|US4221219 *||Jul 31, 1978||Sep 9, 1980||Metal Bellows Corporation||Implantable infusion apparatus and method|
|US4258711 *||Sep 17, 1979||Mar 31, 1981||Metal Bellows Corporation||Infusion apparatus and method|
|US4286584 *||Oct 15, 1979||Sep 1, 1981||Infusaid Corporation||Septum locating apparatus|
|US4299220 *||May 3, 1979||Nov 10, 1981||The Regents Of The University Of Minnesota||Implantable drug infusion regulator|
|US4360019 *||Mar 31, 1980||Nov 23, 1982||Andros Incorporated||Implantable infusion device|
|US4368737 *||Jul 7, 1980||Jan 18, 1983||Purdue Research Foundation||Implantable catheter|
|US4373527 *||Apr 27, 1979||Feb 15, 1983||The Johns Hopkins University||Implantable, programmable medication infusion system|
|US4417888 *||Mar 15, 1982||Nov 29, 1983||Renal Systems, Inc.||Percutaneous implant|
|US4447237 *||May 7, 1982||May 8, 1984||Dow Corning Corporation||Valving slit construction and cooperating assembly for penetrating the same|
|US4464178 *||Nov 25, 1981||Aug 7, 1984||Dalton Michael J||Method and apparatus for administration of fluids|
|US4496343 *||Feb 6, 1984||Jan 29, 1985||Infusaid Corporation||Infusate pump|
|US4505710 *||May 13, 1983||Mar 19, 1985||Collins Earl R||Implantable fluid dispensing system|
|US4525165 *||Nov 4, 1982||Jun 25, 1985||The Johns Hopkins University||Fluid handling system for medication infusion system|
|US4543088 *||Nov 7, 1983||Sep 24, 1985||American Hospital Supply Corporation||Self-sealing subcutaneous injection site|
|US4552561 *||Dec 23, 1982||Nov 12, 1985||Alza Corporation||Body mounted pump housing and pump assembly employing the same|
|US4573994 *||Dec 7, 1981||Mar 4, 1986||The Johns Hopkins University||Refillable medication infusion apparatus|
|US4576211 *||May 7, 1984||Mar 18, 1986||Farmitalia Carlo Erba S.P.A.||Safety device for connection of a syringe with the mouth or opening of a bottle containing a drug or a small tube for drug delivery from the syringe|
|US4588394 *||Mar 16, 1984||May 13, 1986||Pudenz-Schulte Medical Research Corp.||Infusion reservoir and pump system|
|US4604090 *||Nov 22, 1983||Aug 5, 1986||Consolidated Controls Corporation||Compact implantable medication infusion device|
|US4619652 *||Aug 19, 1985||Oct 28, 1986||Alza Corporation||Dosage form for use in a body mounted pump|
|US4655765 *||Jun 1, 1984||Apr 7, 1987||Parker Hannifin Corporation||Fitting with prestressed septum|
|US4673391 *||May 30, 1984||Jun 16, 1987||Koichi Sakurai||Non-contact controlled micropump|
|US4687468 *||Jul 25, 1986||Aug 18, 1987||Cook, Incorporated||Implantable insulin administration device|
|US4692146 *||Oct 24, 1985||Sep 8, 1987||Cormed, Inc.||Multiple vascular access port|
|US4692147 *||Jul 19, 1985||Sep 8, 1987||Medtronic, Inc.||Drug administration device|
|US4695273 *||Apr 8, 1986||Sep 22, 1987||I-Flow Corporation||Multiple needle holder and subcutaneous multiple channel infusion port|
|US4718893 *||Feb 3, 1986||Jan 12, 1988||University Of Minnesota||Pressure regulated implantable infusion pump|
|US4731051 *||Feb 15, 1983||Mar 15, 1988||The Johns Hopkins University||Programmable control means for providing safe and controlled medication infusion|
|US4760837 *||Feb 19, 1987||Aug 2, 1988||Inamed Development Company||Apparatus for verifying the position of needle tip within the injection reservoir of an implantable medical device|
|US4781680 *||Mar 2, 1987||Nov 1, 1988||Vir Engineering||Resealable injection site|
|US4810246 *||Nov 4, 1987||Mar 7, 1989||L. Vad Technology, Inc.||Disposable cell culture chamber with remote access|
|US4820273 *||Mar 1, 1988||Apr 11, 1989||Eaton Corporation||Implantable medication infusion device and bolus generator therefor|
|US4826487 *||May 4, 1987||May 2, 1989||Victory Engineering Company||Alignment button for stereotaxic plug and method of using the same|
|US4832054 *||Jul 7, 1986||May 23, 1989||Medical Engineering Corporation||Septum|
|US4834713 *||Oct 30, 1987||May 30, 1989||Best Industries, Inc.||Catheter buttons|
|US4857053 *||Aug 29, 1988||Aug 15, 1989||Dalton Michael J||Matrix septum|
|US4871351 *||Aug 26, 1987||Oct 3, 1989||Vladimir Feingold||Implantable medication infusion system|
|US4892518 *||Dec 4, 1987||Jan 9, 1990||Biocontrol Technology, Inc.||Hemodialysis|
|US4904241 *||Oct 21, 1988||Feb 27, 1990||Medical Engineering Corp.||Septum with a needle stop at the fluid transfer port|
|US4922926 *||Oct 11, 1988||May 8, 1990||Siemens Aktiengesellschaft||Arrangement for delivering medications in an implantable medical device|
|US4931050 *||Apr 13, 1988||Jun 5, 1990||Shiley Infusaid Inc.||Constant pressure variable flow pump|
|US4955861 *||Apr 21, 1988||Sep 11, 1990||Therex Corp.||Dual access infusion and monitoring system|
|US5006115 *||Jul 25, 1989||Apr 9, 1991||Medtronic, Inc.||Needle placement sensor|
|US5009644 *||Jul 25, 1989||Apr 23, 1991||Medtronic, Inc.||Needle placement verifier|
|US5053031 *||Mar 21, 1989||Oct 1, 1991||Baxter International Inc.||Pump infusion system|
|US5061242 *||Jul 18, 1989||Oct 29, 1991||Infusaid, Inc.||Adjustable implantable drug infusion system|
|US5085656 *||May 9, 1990||Feb 4, 1992||Annemarie Schlogl GmbH & Co. KG||Implantable device for the dosed administration of medicaments to the human body|
|US5088983 *||Jul 1, 1991||Feb 18, 1992||Infusaid, Inc.||Pressure regulator for implantable pump|
|US5135497 *||Jul 8, 1991||Aug 4, 1992||Baxter International Inc.||Large volume pressurized fluid dispenser|
|US5135502 *||Mar 13, 1990||Aug 4, 1992||Medfusion Inc.||Solid introducer for catheter to a port and method of use|
|US5137529 *||Apr 2, 1991||Aug 11, 1992||Pudenz-Schulte Medical Research Corporation||Injection port|
|US5176644 *||Nov 29, 1990||Jan 5, 1993||Minimed Technologies, Ltd.||Medication infusion pump with improved liquid-vapor pressure reservoir|
|US5176653 *||Jul 9, 1991||Jan 5, 1993||Joel Metals||Improvements to implantable vascular access devices|
|US5180365 *||Feb 15, 1991||Jan 19, 1993||Ensminger William D||Implantable infusion device|
|US5201728 *||May 3, 1991||Apr 13, 1993||Giampapa Vincent C||Subcutaneous implantable multiple-agent delivery system|
|US5207644 *||May 11, 1989||May 4, 1993||Strecker Ernst P||Device with implantable infusion chamber and a catheter extending therefrom|
|US5248301 *||Nov 27, 1989||Sep 28, 1993||Medfusion, Inc.||Transcutaneous infusion apparatus and methods of manufacture and use|
|US5281210 *||Sep 18, 1992||Jan 25, 1994||Infusaid, Inc.||Accumulator for implantable pump|
|US5318540 *||Oct 6, 1992||Jun 7, 1994||Pharmetrix Corporation||Controlled release infusion device|
|US5328465 *||Oct 30, 1992||Jul 12, 1994||Medtronic, Inc.||Apparatus and method for limiting access to septum|
|US5395324 *||Jun 3, 1992||Mar 7, 1995||Anschutz + Co., GmbH||Apparatus for the reliable filling of the container of an infusion pump|
|US5443450 *||Apr 29, 1994||Aug 22, 1995||Medtronic, Inc.||Medication delivery device and method of construction|
|US5445616 *||Apr 29, 1994||Aug 29, 1995||Medtronic, Inc.||Medication delivery device and method of construction|
|US5507737 *||Apr 22, 1994||Apr 16, 1996||Siemens Elema Ab||Apparatus for determining the volume of a bellows reservoir for medication in an implantable infusion system|
|US5527277 *||Jun 6, 1995||Jun 18, 1996||Michigan Transtech Corporation||Implantable access devices|
|US5527307 *||Apr 1, 1994||Jun 18, 1996||Minimed Inc.||Implantable medication infusion pump with discharge side port|
|US5551849 *||Apr 29, 1994||Sep 3, 1996||Medtronic, Inc.||Medication delivery device and method of construction|
|US5556381 *||Jun 6, 1995||Sep 17, 1996||The Michigan Transtech Corporation||Implantable access devices|
|US5558640 *||Mar 8, 1995||Sep 24, 1996||Siemens Aktiengesellschaft||System for infusion of medicine into the body of a patient|
|US5607418 *||Aug 22, 1995||Mar 4, 1997||Illinois Institute Of Technology||Implantable drug delivery apparatus|
|US5637088 *||Sep 14, 1995||Jun 10, 1997||Wenner; Donald E.||System for preventing needle displacement in subcutaneous venous access ports|
|US5667504 *||Oct 11, 1994||Sep 16, 1997||Baumann; Hans||Process for the adjustment of a switchable flow limiting apparatus, and an apparatus operating according to the process|
|US5707361 *||Mar 8, 1995||Jan 13, 1998||Siemens Aktiengesellscahaft||Implantable infusion system with a neutral pressure medication container|
|US5722957 *||Mar 15, 1996||Mar 3, 1998||Fresenius Ag||Implantable infusion pump|
|US5752930 *||Sep 20, 1996||May 19, 1998||Medtronic, Inc.||Implantable techniques for infusing equal volumes of agents to spaced sites|
|US5785681 *||Feb 25, 1997||Jul 28, 1998||Minimed Inc.||Flow rate controller for a medication infusion pump|
|US5814019 *||Mar 15, 1996||Sep 29, 1998||Fresenius Ag||Implantable infusion pump|
|US5890271 *||Jul 30, 1997||Apr 6, 1999||Davco Packing And Seals, Inc.||Insertion tool|
|US5897528 *||Apr 30, 1998||Apr 27, 1999||Medtronic, Inc.||Filtered intracerebroventricular or intraspinal access port with direct cerebrospinal fluid access|
|US5928195 *||Jul 28, 1998||Jul 27, 1999||Malamud; Daniel||Remote control drug delivery device|
|US6039712 *||Nov 4, 1997||Mar 21, 2000||Terence M. Fogarty||Implantable injection port|
|US6048328 *||Feb 2, 1998||Apr 11, 2000||Medtronic, Inc.||Implantable drug infusion device having an improved valve|
|US6053891 *||May 13, 1998||Apr 25, 2000||Decampli; William M.||Apparatus and methods for providing selectively adjustable blood flow through a vascular graft|
|US6168575 *||Jan 29, 1998||Jan 2, 2001||David Pyam Soltanpour||Method and apparatus for controlling intraocular pressure|
|US6228050 *||Apr 30, 1999||May 8, 2001||Medtronic Inc.||Overfill protection systems for implantable drug delivery devices|
|US6238367 *||Apr 28, 2000||May 29, 2001||Medtronic, Inc.||Electrical connector for transducer of implantable drug infusion device|
|US6280416 *||Feb 19, 1999||Aug 28, 2001||Minimed Inc.||Constant flow medication infusion pump|
|US6283943 *||Feb 19, 1999||Sep 4, 2001||Minimed Inc.||Negative pressure pump|
|US6283949 *||Dec 27, 1999||Sep 4, 2001||Advanced Cardiovascular Systems, Inc.||Refillable implantable drug delivery pump|
|US6572583 *||Apr 28, 2000||Jun 3, 2003||Medtronic, Inc.||Bulkhead for implantable infusion device|
|US6589198 *||Jun 5, 2000||Jul 8, 2003||David Soltanpour||Implantable micro-pump assembly|
|US20030082507 *||Oct 31, 2001||May 1, 2003||Stypulkowski Paul H.||System and method of treating stuttering by neuromodulation|
|US20030088236 *||Jun 27, 2002||May 8, 2003||Johnson Randolph Mellus||Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7517335||Feb 18, 2003||Apr 14, 2009||Cequr Aps||Device for administering of medication in fluid form|
|US7914499||Mar 28, 2007||Mar 29, 2011||Valeritas, Inc.||Multi-cartridge fluid delivery device|
|US7931643 *||Jul 21, 2006||Apr 26, 2011||Medtronic, Inc.||Miniature pump for drug delivery|
|US8876795||Feb 2, 2012||Nov 4, 2014||The Charles Stark Draper Laboratory, Inc.||Drug delivery apparatus|
|US8945064||Aug 21, 2008||Feb 3, 2015||Cequr Sa||Device for administering of medication in fluid form|
|US9046192 *||Jan 31, 2008||Jun 2, 2015||The Charles Stark Draper Laboratory, Inc.||Membrane-based fluid control in microfluidic devices|
|US9072828||Dec 16, 2008||Jul 7, 2015||Valeritas, Inc.||Hydraulically actuated pump for long duration medicament administration|
|US9089636||Jul 5, 2005||Jul 28, 2015||Valeritas, Inc.||Methods and devices for delivering GLP-1 and uses thereof|
|US20050165384 *||Feb 18, 2003||Jul 28, 2005||Danfoss A/S||Device for administering of medication in gluid form|
|WO2008045308A2 *||Oct 5, 2007||Apr 17, 2008||Anil B Kumar||Balloon catheter with manually operated valve and aspirator|
|International Classification||A61K9/22, A61M5/142, A61M5/145|
|Cooperative Classification||A61M2209/045, A61M5/14586, A61M5/14276, A61M5/14593|
|European Classification||A61M5/145D, A61M5/145D2, A61M5/142P10|
|Oct 14, 2008||AS||Assignment|
Owner name: INSET TECHNOLOGIES INCORPORATED, NEW JERSEY
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:INFUMEDICS, INC.;REEL/FRAME:021701/0484
Effective date: 20081009